4 Biotechs Ready to Kill the Market in 2018 Post author:Sam Post published:December 28, 2017 Post category:BioPharma A look at a few biotechs which should outperform the market in 2018: Source: BioSpace You Might Also Like Nektar Stock Blows Up on Encouraging Data to Treat Difficult Cancers November 12, 2017 SI-BONE Announces Utah's Public Employees Health Plan (PEHP) Establishes Coverage For The Ifuse Procedure For Minimally Invasive SI Joint Fusion October 8, 2017 FDA Grants New Clearance for NICO Corporation's Brain Surgery Technology January 31, 2017
SI-BONE Announces Utah's Public Employees Health Plan (PEHP) Establishes Coverage For The Ifuse Procedure For Minimally Invasive SI Joint Fusion October 8, 2017
